|
|
1 |
According to a study recently published in the Journal of Clinical Oncology, adenosine 5-triphosphate (ATP) appears to improve
energy intake and reduce muscle wasting associated with advanced non-small cell lung cancer patients...Click Here |
2 |
In conclusion, our study shows that intravenous ATP infusion
for 22 to 24 hours is able to restore depleted liver ATP pools in
patients with advanced lung cancer to levels similar to or above
those in healthy subjects. This effect is most marked in weightlosing
lung cancer patients and may contribute to the previously
reported beneficial effects of repeated ATP infusions on the nutritional
status of lung cancer patients...
Click Here |
3 |
Cancer-associated loss of appetite and/or weight occurs in
more than 50% of all patients with advanced cancer. Weight loss and a decline in functional status are often intimately
related. Loss of appetite is one of the most distressing symptoms cancer patients suffer toward the end of life. As
noted earlier, multiple agents have been tried to reverse or prevent loss of weight and loss of appetite, but all fall short:
none causes weight gain and improvement in appetite for the majority of weight-losing cancer patients with advanced
disease...Click Here |
4 |
In conclusion, our results demonstrate
that ATP infusion has marked beneficial
effects on the quality of life of patients with advanced
non-small-cell lung cancer. In patients who are losing
weight, ATP prevents further weight
loss and maintains muscle strength of
both the upper and the lower extremities.... In contrast
to earlier pharmacologic attempts to
reverse cancer cachexia, it appears that
ATP might be the first agent with beneficial
effects on skeletal muscles of cachectic cancer patients...Click Here |
